Internal Medicine, Endocrinology, Diabetes, & Metabolism · Livonia, MI
NPI
1144208232
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
37650 Professional Center Dr, Suite 100a
Livonia, MI, 48154
Phone (734) 462-1940
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
839 services
Medicare patients, 2024
219
Average age 73
Drug cost, 2024
$1.7M
4,608 prescriptions
Company payments, 2025
$447
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacqueline F Fabello-Gamiao was code 99214 (office e&m - established), 545 times for 205 patients. In total Jacqueline F Fabello-Gamiao billed 839 services in 11 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 545 | 205 | $95.21 | $52K |
| 82962 Clinical Chemistry | Office | 133 | 61 | $3.19 | $424 |
| 95251 Test - Miscellaneous | Office | 91 | 41 | $27.05 | $2,462 |
| 99204 Office E&M - New | Office | 49 | 49 | $123.65 | $6,059 |
By year: 2022 $44K for 543 services; 2023 $52K for 702 services; 2024 $62K for 839 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 133 | 61 | $3.19 | $424 |
Medicare prescription drug claims, 2024
In 2024, the drug Jacqueline F Fabello-Gamiao prescribed most often to Medicare patients was Levoxyl (Levothyroxine Sodium), with 404 prescriptions and refills. In total Jacqueline F Fabello-Gamiao wrote 4,608 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levoxyl Levothyroxine Sodium | 404 | 1,049 | 121 | $11K |
| Synthroid Levothyroxine Sodium | 341 | 883 | 90 | $35K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 265 | 735 | 91 | $58K |
| Jardiance Empagliflozin | 227 | 515 | 72 | $286K |
| Metformin Hcl Er Metformin Hcl | 203 | 591 | 72 | $4,298 |
| Atorvastatin Calcium Generic | 187 | 519 | 60 | $2,254 |
| Ozempic Semaglutide | 171 | 275 | 35 | $250K |
| Losartan Potassium Generic | 154 | 403 | 45 | $1,817 |
| Januvia Sitagliptin Phosphate | 144 | 300 | 36 | $159K |
| Rosuvastatin Calcium Generic | 130 | 347 | 42 | $2,276 |
| Levothyroxine Sodium Generic | 123 | 339 | 47 | $1,729 |
| Metformin Hcl Generic | 109 | 272 | 32 | $1,185 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 101 | 258 | 40 | $11K |
| Farxiga Dapagliflozin Propanediol | 93 | 213 | 25 | $113K |
| Unithroid Levothyroxine Sodium | 92 | 229 | 25 | $2,709 |
Brand drugs: 2,491 claims; generic drugs: 1,769 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacqueline F Fabello-Gamiao $447 ($447 in general payments such as food, travel and fees) from 8 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $121.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.